Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$562.76M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$566.43M
Quick Ratio (Acid-Test)
2.36
TTM Avg
2.55
3Y Avg
5.33
5Y Avg
7.55
Market Cap
$548.18M
Quick Ratio (Acid-Test)
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$548.84M
Quick Ratio (Acid-Test)
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$546.52M
Quick Ratio (Acid-Test)
1.68
TTM Avg
2.23
3Y Avg
2.63
5Y Avg
2.59
Market Cap
$572.76M
Quick Ratio (Acid-Test)
6.74
TTM Avg
3.69
3Y Avg
2.52
5Y Avg
2.35
Market Cap
$540.01M
Quick Ratio (Acid-Test)
1.87
TTM Avg
2.92
3Y Avg
5.55
5Y Avg
6.22
Market Cap
$538.54M
Quick Ratio (Acid-Test)
8.95
TTM Avg
10.43
3Y Avg
5.97
5Y Avg
5.34
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $562.76M | 9.36 | 2.17 | 1.76 | 2.63 |
| CorMedix Inc. (CRMD)vs › | $566.43M | 2.36 | 2.55 | 5.33 | 7.55 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $548.18M | 5.42 | 12.18 | 12.18 | 12.18 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $548.84M | 3.46 | 4.63 | 6.00 | 6.13 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $546.52M | 1.68 | 2.23 | 2.63 | 2.59 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $572.76M | 6.74 | 3.69 | 2.52 | 2.35 |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $540.01M | 1.87 | 2.92 | 5.55 | 6.22 |
| Delcath Systems, Inc. (DCTH)vs › | $538.54M | 8.95 | 10.43 | 5.97 | 5.34 |
| ProKidney Corp. (PROK)vs › | $534.64M | 8.36 | 10.03 | 20.35 | 14.11 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
